Table 2.
Clinicopathologic characteristics of the study cohort.
| Variables | Number (%) |
|---|---|
| Total | 319 |
| Healthy controls | 70 (21.9) |
| Age (years) | |
| Mean ± SD | 33 ± 14 |
| Range (Median) | 21–67 (27) |
| Gender | |
| Male | 35 (50.0) |
| Female | 35 (50.0) |
| Benign conditions | 111 (34.8) |
| Age (years) | |
| Mean ± SD | 57 ± 15 |
| Range (Median) | 13–84 (59) |
| Gender | |
| Male | 62 (55.9) |
| Female | 49 (44.1) |
| CP | 58 (52.3) |
| IPMN | 53 (47.7) |
| PDAC | 138 (43.3) |
| Age (years) | |
| Mean ± SD | 65 ± 10 |
| Range (Median) | 30–92 (65) |
| Gender | |
| Male | 64 (46.4) |
| Female | 74 (53.6) |
| Early stage | 56 (40.6) |
| IA/IB/IIA/IIB | 5/6/9/36 |
| Late stage | 82 (59.4) |
| III/IV | 19/63 |
NOTE: CP, chronic pancreatitis. IPMN, intraductal papillary mucinous neoplasm.